Elixirgen Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 7

EPO Patents = 2

Trademarks = 3

Forward Citations = 10

Loading Chart...

2 inventors (with patents filed for the assignee):

Minoru S H Ko (5 out of 12 patents)

Minoru Sh Ko (2 out of 3 patents)

Minoru SH Ko (0 patent)

7 patents: Sort by Forward Citations

1. 12478659 - METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS (2025-11-25),

2. 12478657 - METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS (2025-11-25),

3. 12060568 - Temperature-based transient delivery of nucleic acids and proteins to cells and tissues (2024-08-13),

4. 11421248 - Temperature-based transient delivery of nucleic acids and proteins to cells and tissues (2022-08-23),

5. 11389504 - Methods of using ZSCAN4 for rejuvenating human cells (2022-07-19),

6. 10744183 - Methods of using ZSCAN4 for rejuvenating human cells (2020-08-18),

7. 10335456 - Methods of using ZSCAN4 for rejuvenating human cells (2019-07-02),

Company Overview

Elixirgen Therapeutics, Inc. is a biotechnology company specializing in the development of stem cell technologies for drug discovery and regenerative medicine. With a focus on induced pluripotent stem cells (iPSCs), Elixirgen Therapeutics aims to provide innovative solutions for the pharmaceutical and healthcare industries. Their cutting-edge research and technology have the potential to revolutionize the way diseases are studied and treated.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#75 in Baltimore, MD

#569 in Maryland

#39,950 in US

Baltimore, MD, United States of America

Elixirgen Therapeutics, Inc.

Forward Citations = 10

2 inventors:

Minoru S H Ko (5 out of 12 patents)

Minoru Sh Ko (2 out of 3 patents)

Minoru SH Ko (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elixirgen Therapeutics, Inc.. Retrieved from https://idiyas.com/company/elixirgen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]